A high drama is currently playing out in a small corner of the financial markets, perhaps the last place that any ordinary investor – as a Hollywood producer – might think to see. While many of the details are knee-jerk in financial market jargon, from short coverage to triple charges …
Read More »
Text size Sanofi is limiting its focus on drug development, stopping its diabetes and cardiovascular research. Joel Saget / AFP via Getty Images French pharmaceutical giant Sanofi is digging into the cash it raised earlier this year with the sale of its $ 11.7 billion stake in Regeneron Pharmaceuticals, the …
Read More »
COVID-19 is still raging, traders are starting to bet on “hornworms around the election,” and the US and China could not even agree on planning a scheduled meeting over the weekend. None of this is, of course, significant to the stock market. Goldman Sachs became the latest company to increase …
Read More »
The S&P 500 index is crawling to the brink of a rare barrage, and persistent uncertainties created by the COVID-19 pandemic in its rise. Although the most important benchmark of the stock in the world is likely to have climbed to a record, the rally has been postponed by the …
Read More »
Analysts at BofA Securities and Morgan Stanley upgraded their ratings on Tesla Inc. shares on Friday, tinning the ranks of Tesla bears and increasing the stock to another record. Tesla TSLA, + 1.98% stock is on Friday for another very high, and has almost doubled in price this year. Earlier …
Read More »